Notch-regulated MIR-223 targets the aryl hydrocarbon receptor pathway and increases cytokine production in macrophages from rheumatoid arthritis patients

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ogando, Jesús ^a   Tardáguila, Manuel ^a   Díaz Alderete, Andrea ^a   Usategui, Alicia ^b   Miranda Ramos, Vanessa ^b   Martínez Herrera, Dannys Jorge ^a   De La Fuente, Lorena ^c   García León, María J ^d   Moreno, María C ^a   Escudero, Sara ^a   Cañete, Juan D ^e   Toribio, María L ^d   Cases, Ildefonso ^f   Pascual Montano, Alberto ^a   Pablos, José Luis ^b   Mañes, Santos ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b Instituto de Investigación Hospital 12 de Octubre ^*  (Spain)

^c CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^d CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f Institut de Medicina Predictiva i Personalitzada del Cancer IMPPC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARNT PROTEIN, HUMAN; CYTOKINE; HYPOXIA INDUCIBLE FACTOR 1BETA; MICRORNA; MIRN223 MICRORNA, HUMAN; NOTCH RECEPTOR;

AGED; COCULTURE; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HEK293 CELL LINE; HUMAN; MACROPHAGE; MALE; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS; PATHOLOGY; PROCEDURES; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

AGED; ARTHRITIS, RHEUMATOID; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; COCULTURE TECHNIQUES; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; HEK293 CELLS; HUMANS; MACROPHAGES; MALE; MICRORNAS; MIDDLE AGED; OSTEOARTHRITIS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 84957837002     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20223     Document Type: Article

References (49)

1. Hamilton, J. A. & Tak, P. P. The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum 60, 1210-1221 (2009).
2. Tak, P. P. et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 40, 217-225 (1997).
3. Okamoto, H., Hoshi, D., Kiire, A., Yamanaka, H. & Kamatani, N. Molecular targets of rheumatoid arthritis. Inflamm Allergy Drug Targets 7, 53-66 (2008).
4. Wijbrandts, C. A. et al. Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker. Arthritis Rheum 56, 3869-3871 (2007).
5. Valinezhad Orang, A., Safaralizadeh, R. & Kazemzadeh-Bavili, M. Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-specific upregulation. Int J Genomics 2014, 970607 (2014).
6. Ansel, K. M. RNA regulation of the immune system. Immunol Rev 253, 5-11 (2013).
7. Baxter, D., McInnes, I. B. & Kurowska-Stolarska, M. Novel regulatory mechanisms in inflammatory arthritis: a role for microRNA. Immunol Cell Biol 90, 288-292 (2012).
8. Pers, Y. M. & Jorgensen, C. MicroRNA in 2012: Biotherapeutic potential of microRNAs in rheumatic diseases. Nat Rev Rheumatol 9, 76-78 (2013).
9. Miyaki, S. & Asahara, H. Macro view of microRNA function in osteoarthritis. Nat Rev Rheumatol 8, 543-552 (2012).
10. Hankinson, O. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35, 307-340 (1995).
11. Kallberg, H. et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 70, 508-511 (2011).
12. Stockinger, B., Hirota, K., Duarte, J. & Veldhoen, M. External influences on the immune system via activation of the aryl hydrocarbon receptor. Semin Immunol 23, 99-105 (2011).
13. Huang, G. & Elferink, C. J. A novel nonconsensus xenobiotic response element capable of mediating aryl hydrocarbon receptordependent gene expression. Mol Pharmacol 81, 338-347 (2012).
14. Tamaki, A. et al. Polycyclic aromatic hydrocarbon increases mRNA level for interleukin 1 beta in human fibroblast-like synoviocyte line via aryl hydrocarbon receptor. Biol Pharm Bull 27, 407-410 (2004).
15. Kimura, A., Naka, T., Nohara, K., Fujii-Kuriyama, Y. & Kishimoto, T. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc Nat Acad Sci USA 105, 9721-9726 (2008).
16. Quintana, F. J. et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65-71 (2008).
17. Veldhoen, M. et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106-109 (2008).
18. Nakahama, T. et al. Aryl hydrocarbon receptor deficiency in T cells suppresses the development of collagen-induced arthritis. Proc Nat Acad Sci USA 108, 14222-14227 (2011).
19. Apetoh, L. et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol 11, 854-861 (2010).
20. Quintana, F. J. et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Nat Acad Sci USA 107, 20768-20773 (2010).
21. Kimura, A. et al. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J Exp Med 206, 2027-2035 (2009).
22. Sekine, H. et al. Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharide-induced septic shock. Mol Cell Biol 29, 6391-6400 (2009).
23. Huai, W. et al. Aryl hydrocarbon receptor negatively regulates NLRP3 inflammasome activity by inhibiting NLRP3 transcription. Nat Commun 5, 4738 (2014).
24. Freemont, A. J. & Denton, J. Atlas of synovial fluid cytopathology (Springer-Science, 1991).
25. Segura, E. et al. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 38, 336-348 (2013).
26. Soler Palacios, B. et al. Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent proinflammatory profile. J Pathol 235, 515-526 (2015).
27. Fulci, V. et al. miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum Immunol 71, 206-211 (2010).
28. Li, Y. T. et al. Brief report: amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223. Arthritis Rheum 64, 3240-3245 (2012).
29. Shibuya, H. et al. Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation. Mod Rheumatol 23, 674-685 (2013).
30. Filkova, M. et al. Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. Ann Rheum Dis 73, 1898-1904 (2014).
31. Lu, M. C. et al. Increased miR-223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin-like growth factor-1-mediated interleukin-10 production. Clin Exp Immunol 177, 641-651 (2014).
32. You, S. et al. Identification of key regulators for the migration and invasion of rheumatoid synoviocytes through a systems approach. Proc Nat Acad Sci USA 111, 550-555 (2014).
33. Lee, H. M. et al. Abnormal networks of immune response-related molecules in bone marrow cells from patients with rheumatoid arthritis as revealed by DNA microarray analysis. Arthritis Res Ther 13, R89 (2011).
34. Yoshida, H. et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345, 442-444 (1990).
35. Geling, A., Steiner, H., Willem, M., Bally-Cuif, L. & Haass, C. A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep 3, 688-694 (2002).
36. Bauernfeind, F. et al. NLRP3 inflammasome activity is negatively controlled by miR-223. J Immunol 189, 4175-4181 (2012).
37. Chen, Q. et al. Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1beta production in macrophages by targeting STAT3. PloS One 7, e42971 (2012).
38. Li, T. et al. MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nat Immunol 11, 799-805 (2010).
39. Lee, J. S. et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat Immunol 13, 144-151 (2012).
40. Gusscott, S., Kuchenbauer, F., Humphries, R. K. & Weng, A. P. Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL. Leuk Res 36, 905-911 (2012).
41. Kumar, V. et al. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. Leukemia 28, 2324-2335 (2014).
42. Franco, C. B. et al. Notch/Delta signaling constrains reengineering of pro-T cells by PU.1. Proc Natl Acad Sci USA 103, 11993-11998 (2006).
43. Choi, K. et al. Distinct biological roles for the notch ligands Jagged-1 and Jagged-2. The J Biol Chem 284, 17766-17774 (2009).
44. Van de Walle, I. et al. Specific Notch receptor-ligand interactions control human TCR-alphabeta/gammadelta development by inducing differential Notch signal strength. J Exp Med 210, 683-697 (2013).
45. Gama-Norton, L. et al. Notch signal strength controls cell fate in the haemogenic endothelium. Nat Commun 6, 8510 (2015).
46. Petrovic, J. et al. Ligand-dependent Notch signaling strength orchestrates lateral induction and lateral inhibition in the developing inner ear. Development 141, 2313-2324 (2014).
47. Nguyen, N. T. et al. Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research. Front Immunol 5, 551 (2014).
48. Wightman, B., Ha, I. & Ruvkun, G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75, 855-862 (1993).
49. Herberth, G. et al. Maternal and cord blood miR-223 expression associates with prenatal tobacco smoke exposure and low regulatory T-cell numbers. J Allergy Clin Immunol 133, 543-550 (2014).